You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice

About Guidelines Email Guidelines Team

Chemotherapy

The guidelines and other documents available here provide recommendations on safe and effective chemotherapy for people with cancer in Ontario.

Displaying Guidelines

142 Items

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Document Status: Archived
ID: 3-12

Nov 2011

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Document Status: Archived
ID: 2-10

Sep 2011

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-16b
Version: 2

Sep 2011

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-16

Sep 2011

Use of Neoadjuvant Chemotherapy in Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-2 Version 2
Version: 2

Nov 2012

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Document Status: Archived
ID: 7-4
Version: 2

Dec 2017

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-17

Sep 2011

Vinorelbine in Stage IV Breast Cancer

Document Status: Archived
ID: 1-4

Sep 2012

Zoledronic Acid as Adjuvant Therapy in Combination with Adjuvant Endocrine Therapy for Premenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

Document Status: Archived
ID: CED 16

Jan 2010

Zoledronic Acid for Metastatic Renal Cell Carcinoma (MRCC)

Document Status: Archived
ID: CED 18

Jun 2010